For research use only
| Cat No. | ABC-X0344C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Fibroblast |
| Species | Human |
| Host Cell | NIH/3T3 |
| Source Organ | Embryo |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human EML4_ALK (F1174L_G1202R) NIH/3T3 Cell Line is designed for evaluating oncogenic ALK variants and resistance development in cancer research.
Human EML4_ALK (F1174L_G1202R) NIH/3T3 Overexpression Cell Line is a dual-mutant NIH/3T3 system stably expressing EML4-ALK fusion with F1174L and G1202R mutations. Cells are validated by qRT-PCR and maintained at low passage.
| Species | Human |
| Cat.No | ABC-X0344C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Embryo |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | NIH/3T3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
This cell line is well-suited for evaluating drug candidates that overcome dual ALK mutations and for understanding tumor evolution in the context of targeted therapy.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).